| Pharmaceutical active ingredients: |
| Mitoxantrone Hydrochloride |
| Available forms, composition and doses of Mitoxantrone: |
| Injectable; Injection; Mitoxantrone Hydrochloride 2 mg / ml |
| Mitoxantrone medical category: |
| Human:Antineoplastic agentsCytotoxic chemotherapy |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| L01DB07 - Mitoxantrone |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Wockhardt |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Mitoxantrone | Mitoxantrone Hydrochloride | Mylan |
| Mitoxantrone | Mitoxantrone Hydrochloride | Novopharm |
| Mitoxantrone | Mitoxantrone Hydrochloride | Pharmaceutical Partners of Canada |
| Mitoxantrone | Mitoxantrone Hydrochloride | Sicor Pharmaceuticals |
| Mitoxantrone | Mitoxantrone Hydrochloride | Teva |
| Mitoxgen | Mitoxantrone Hydrochloride | Armstrong Laboratorios de Mexico; Bioprofarma |
| Mitroxone | Mitoxantrone Hydrochloride | Columbia Laboratorios |
| Neotalem | Mitoxantrone Hydrochloride | Teva; Chile Laboratorios; Lemery |
| Novantron | Mitoxantrone Hydrochloride | Wyeth; AHP Schweiz; Meda |
| Novantrone | Mitoxantrone Hydrochloride | Wyeth; Dexxon; Immunex; Meda; Neopharm, Israel; Serono; Sigma Pharmaceuticals; Zuellig Pharma |